Biophagy’s Proprietary Drug Development
Biophagy is positioned as a discovery pharmaceutical company with a proprietary drug development program in anti-infectives and neurodegenerative disease. Its goal is to bring lead compounds into pre-clinical development and then to partner with a larger company for advanced testing and clinical trials.
Biophagy’s patented chemical libraries encompass compounds active in models of tuberculosis, SARS-CoV-2 (covid-19), and neurodegenerative diseases.
Biophagy has developed its programs in collaboration with the following outstanding institutions:
- Sandia National Laboratories
- New Mexico Small Business Assistance
- University of New Mexico
- Los Alamos National Laboratories